Aclaris Therapeutics Inc (ACRS)

Cost of Revenue

$231.00K

Quarterly · Period ending: · USD

ACRS logo

ACRS Cost of Revenue

Latest reported$231.00K
ACRS Quarterly Cost of Revenue ($0.00 → $231.00K)
High-resolution chart · PNG

ACRS cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aclaris Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
231,000
395,000
-803,000
538,000
1,850,000
506,000
9,301,000
2,408,000
1,909,000
1,840,000
6,428,000
8,192,000
1,592,000
1,869,000
1,514,000
8,223,000
1,068,000
1,155,000
1,149,000
1,099,000
1,263,000
1,202,000
1,286,000
1,189,000
1,389,000
1,269,000
1,027,000
826,000
2,703,000
2,777,000
3,509,000
1,193,000
1,181,000
967,000
754,000
453,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.